Metastatic malignancies and the effect on arterial stiffness and blood pressure levels: the possible role of chemotherapy

References

• HeidenreichPATrogdonJGKhavjouOAForecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart AssociationCirculation201112393394421262990
   PubMed Web of Science ®Google Scholar
• StoneNJRobinsonJLichtensteinAH2013 ACC/AHA Guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice GuidelinesCirculation2014129145
   PubMed Web of Science ®Google Scholar
• LenihanDJCardinaleDCipollaCMThe compelling need for a cardiology and oncology partnership and the birth of the International CardiOncology SocietyProg Cardiovasc Dis201053889320728695
   PubMed Web of Science ®Google Scholar
• JonesLWHaykowskyMJSwartzJJDouglasPSMackeyJREarly breast cancer therapy and cardiovascular injuryJ Am Coll Cardiol2007501435144117919562
   PubMed Web of Science ®Google Scholar
• de HaasECOostingSFLefrandtJDWolffenbuttelBHSleijferDTGietemaJAThe metabolic syndrome in cancer survivorsLancet Oncol201011219320320152771
   PubMed Web of Science ®Google Scholar
• JemalASiegelRWardEHaoYXuJThunMJCancer statistics, 2009CA Cancer J Clin20092009225249
   Web of Science ®Google Scholar
• KindlerHLShulmanKLMetastatic colorectal cancerCurr Treat Options Oncol2001245947112057092
   PubMedGoogle Scholar
• KopetzSChangGJOvermanMJImproved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapyJ Clin Oncol2009273677368319470929
   PubMed Web of Science ®Google Scholar
• van CutsemEKöhneCHHitreECetuximab and chemotherapy as initial treatment for metastatic colorectal cancerN Engl J Med20093601408141719339720
   PubMed Web of Science ®Google Scholar
• BeeramMPatnaikARowinskyEKRaf: a strategic target for therapeutic development against cancerJ Clin Oncol2005236771679016170185
   PubMed Web of Science ®Google Scholar
• MendelDBLairdADXinXIn vivo antitumor activity of SU11248, a novel tyrosine kinase inhibitor targeting vascular endothelial growth factor and platelet-derived growth factor receptors: determination of a pharmacokinetic/pharmacodynamic relationshipClin Cancer Res2003932733712538485
   PubMed Web of Science ®Google Scholar
• KerkeläRGrazetteLYacobiRCardiotoxicity of the cancer therapeutic agent imatinib mesylateNat Med20061290891616862153
   PubMed Web of Science ®Google Scholar
• VerweijJCasaliPGKotasekDImatinib does not induce cardiac left ventricular failure in gastrointestinal stromal tumours patients: analysis of EORTC-ISG-AGITG study 62005Eur J Cancer20074397497817336514
   PubMed Web of Science ®Google Scholar
• PerikPJRikhofBde JongFAResults of plasma N-terminal pro B-type natriuretic peptide and cardiac troponin monitoring in GIST patients do not support the existence of imatinib-induced cardiotoxicityAnn Oncol20081935936117962203
   PubMed Web of Science ®Google Scholar
• PiepoliMFHoesAWAgewallSLinee guida europee 2016 sulla prevenzione delle malattie cardiovascolari nella pratica clinica [2016 European guidelines on cardiovascular disease prevention in clinical practice]G Ital Cardiol (Rome)2017187547612 Italian28714997
   PubMedGoogle Scholar
• BoyansVRiccoJBBartelinkMEL2017 ESC guidelines on the diagnosis and treatment of peripheral arterial diseases, in collaboration with the European Society for Vascular Surgery (ESVS)Rev Esp Cardiol20187111129425606
   PubMed Web of Science ®Google Scholar
• IoakeimidisNTzifosVVlachopoulosCTerentes-PrintziosDGeorgakopoulosCTousoulisDAcute effect of coffee on aortic stiffness and wave reflections in healthy individuals: differential effect according to habitual consumptionInt J Food Sci Nutr201810112
   Google Scholar
• PietriPVlachopoulosCTerentes-PrintziosDBeneficial effects of low-dose aspirin on aortic stiffness in hypertensive patientsVasc Med20141945245725362110
   PubMed Web of Science ®Google Scholar
• PatnaikJLByersTDiguiseppiCDabeleaDDenbergTDCardiovascular disease competes with breast cancer as the leading cause of death for older females diagnosed with breast cancer: a retrospective cohort studyBreast Cancer Res201113R6421689398
   PubMed Web of Science ®Google Scholar
• MaureaNCoppolaCRagoneGWomen survive breast cancer but fall victim to heart failure: the shadows and lights of targeted therapyJ Cardiovasc Med (Hagerstown)20101186186820072001
   PubMed Web of Science ®Google Scholar
• SchultzPNBeckMLStavaCVassilopoulou-SellinRHealth profiles in 5836 long-term cancer survivorsInt J Cancer200310448849512584748
   PubMed Web of Science ®Google Scholar
• ChaosuwannakitND’AgostinoRJrCraigAAortic stiffness increases upon receipt of anthracycline chemotherapyJ Clin Oncol20102816617219901105
   PubMed Web of Science ®Google Scholar
• DraftsBCTwomleyKMD’AgostinoRJrLow to moderate dose anthracycline-based chemotherapy is associated with early noninvasive imaging evidence of subclinical cardiovascular diseaseJACC Cardiovasc Imaging2013687788523643285
   PubMed Web of Science ®Google Scholar
• SlamonDJLeyland-JonesBShakSUse of chemotherapy plus a monoclonal antibody against Her2 for metastatic breast cancer that overexpresses Her2N Engl J Med200134478379211248153
   PubMed Web of Science ®Google Scholar
• ForceTKrauseDSvan EttenRAMolecular mechanisms of cardiotoxicity of tyrosine kinase inhibitionNat Rev Cancer2007733234417457301
   PubMed Web of Science ®Google Scholar
• StevensonLWPerloffJKThe limited reliability of physical signs for estimating hemodynamics in chronic heart failureJ Am Med Assoc1989261884888
   PubMed Web of Science ®Google Scholar
• SchlessingerJCommon and distinct elements in cellular signaling via EGF and FGF receptorsScience20043061506150715567848
   PubMed Web of Science ®Google Scholar
• HolbroTHynesNEErbB receptors: directing key signaling networks throughout lifeAnnu Rev Pharmacol Toxicol20044419521714744244
   PubMed Web of Science ®Google Scholar
• van CutsemEPeetersMSienaSOpen-label phase III trial of panitumumab plus best supportive care compared with best supportive care alone in patients with chemotherapy-refractory metastatic colorectal cancerJ Clin Oncol2007251658166417470858
   PubMed Web of Science ®Google Scholar
• RougierPvan CutsemEBajettaERandomised trial of irinotecan versus fluorouracil by continuous infusion after fluorouracil failure in patients with metastatic colorectal cancerLancet1998352140714129807986
   PubMed Web of Science ®Google Scholar
• CunninghamDPyrhonenSJamesRDRandomised trial of irinotecan plus supportive care versus supportive care alone after fluorouracil failure for patients with metastatic colorectal cancerLancet1998352141314189807987
   PubMed Web of Science ®Google Scholar